Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats
| dc.contributor.author | Lazarus, David Dazhia | |
| dc.contributor.author | Peta, F. | |
| dc.contributor.author | Blight, D. | |
| dc.contributor.author | Van Heerden, J. | |
| dc.contributor.author | Mutowembwa, P.B. | |
| dc.contributor.author | Heath, L. | |
| dc.contributor.author | Blignaut, Belinda | |
| dc.contributor.author | Opperman, Pamela Anne | |
| dc.contributor.author | Fosgate, Geoffrey Theodore | |
| dc.date.accessioned | 2021-10-04T07:27:04Z | |
| dc.date.available | 2021-10-04T07:27:04Z | |
| dc.date.issued | 2020-05 | |
| dc.description.abstract | Please read abstract in the article. | en_ZA |
| dc.description.department | Production Animal Studies | en_ZA |
| dc.description.librarian | hj2021 | en_ZA |
| dc.description.librarian | 2026es | en |
| dc.description.sdg | SDG-02: Zero hunger | en |
| dc.description.sdg | SDG-03: Good health and well-being | en |
| dc.description.sdg | SDG-09: Industry, innovation and infrastructure | en |
| dc.description.sdg | SDG-12: Responsible consumption and production | en |
| dc.description.sdg | SDG-17: Partnerships for the goals | en |
| dc.description.sponsorship | The National Research Foundation (NRF), South Africa and the Peace Parks Foundation. | en_ZA |
| dc.description.uri | http://www.elsevier.com/locate/vaccine | en_ZA |
| dc.identifier.citation | Lazarus, D.D., Peta, F., Blight, D. et al. 2020, 'Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats', Vaccine, vol. 38, no. 24, pp. 4006-4015. | en_ZA |
| dc.identifier.issn | 0264-410X (print) | |
| dc.identifier.issn | 1873-2518 (online) | |
| dc.identifier.other | 10.1016/j.vaccine.2020.04.014 | |
| dc.identifier.uri | http://hdl.handle.net/2263/82026 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | Elsevier | en_ZA |
| dc.rights | © 2020 Elsevier Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Vaccine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Vaccine, vol. 38, no. 24, pp. 4006-4015, 2020, doi: 10.1016/j.vaccine.2020.04.014. | en_ZA |
| dc.subject | Foot-and-mouth disease virus (FMDV) | en_ZA |
| dc.subject | Foot-and-mouth disease (FMD) | en_ZA |
| dc.subject | Vaccination | en_ZA |
| dc.subject | Dosage | en_ZA |
| dc.subject | Clinical protection | en_ZA |
| dc.subject | Goats | en_ZA |
| dc.subject | Heterologous challenge | en |
| dc.subject | Goats | en |
| dc.subject | Inactivated pentavalent vaccine | en |
| dc.subject | Viral RNA detection | en |
| dc.subject.other | Veterinary science articles SDG-02 | en |
| dc.subject.other | Veterinary science articles SDG-03 | en |
| dc.subject.other | Veterinary science articles SDG-09 | en |
| dc.subject.other | Veterinary science articles SDG-12 | en |
| dc.subject.other | Veterinary science articles SDG-17 | en |
| dc.title | Efficacy of a foot-and-mouth disease vaccine against a heterologous SAT1 virus challenge in goats | en_ZA |
| dc.type | Postprint Article | en_ZA |
